113 related articles for article (PubMed ID: 8589465)
1. Failure of low molecular weight dextran to prevent clotting during continuous renal replacement therapy.
Palevsky PM; Burr R; Moreland L; Tokiwa Y; Greenberg A
ASAIO J; 1995; 41(4):847-9. PubMed ID: 8589465
[TBL] [Abstract][Full Text] [Related]
2. Anticoagulation with prostaglandin E1 and unfractionated heparin during continuous venovenous hemofiltration.
Kozek-Langenecker SA; Kettner SC; Oismueller C; Gonano C; Speiser W; Zimpfer M
Crit Care Med; 1998 Jul; 26(7):1208-12. PubMed ID: 9671370
[TBL] [Abstract][Full Text] [Related]
3. Predilution versus postdilution during continuous venovenous hemofiltration: a comparison of circuit thrombogenesis.
de Pont AC; Bouman CS; Bakhtiari K; Schaap MC; Nieuwland R; Sturk A; Hutten BA; de Jonge E; Vroom MB; Meijers JC; Büller HR
ASAIO J; 2006; 52(4):416-22. PubMed ID: 16883122
[TBL] [Abstract][Full Text] [Related]
4. Factors affecting system clotting in continuous renal replacement therapy: results of a randomized, controlled trial.
Ramesh Prasad GV; Palevsky PM; Burr R; Lesko JM; Gupta B; Greenberg A
Clin Nephrol; 2000 Jan; 53(1):55-60. PubMed ID: 10661483
[TBL] [Abstract][Full Text] [Related]
5. The use of regional citrate anticoagulation continuous venovenous hemofiltration in extracorporeal membrane oxygenation.
Shum HP; Kwan AM; Chan KC; Yan WW
ASAIO J; 2014; 60(4):413-8. PubMed ID: 24727536
[TBL] [Abstract][Full Text] [Related]
6. Citrate clearance in children receiving continuous venovenous renal replacement therapy.
Chadha V; Garg U; Warady BA; Alon US
Pediatr Nephrol; 2002 Oct; 17(10):819-24. PubMed ID: 12376810
[TBL] [Abstract][Full Text] [Related]
7. Maintenance of adequate hemodialysis access. Prevention of neointimal hyperplasia.
Taber TE; Maikranz PS; Haag BW; Gaylord GM; Dilley RS; Ehrman KO; Brown PB; Nelson DR; Kay DC; Roberts TL
ASAIO J; 1995; 41(4):842-6. PubMed ID: 8589464
[TBL] [Abstract][Full Text] [Related]
8. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.
Kalb R; Kram R; Morgera S; Slowinski T; Kindgen-Milles D
Ther Apher Dial; 2013 Apr; 17(2):202-12. PubMed ID: 23551677
[TBL] [Abstract][Full Text] [Related]
9. Heparin versus prostacyclin in continuous hemodiafiltration for acute renal failure: effects on platelet function in the systemic circulation and across the filter.
Arcangeli A; Rocca B; Salvatori G; Ciancia M; De Cristofaro R; Antonelli M
Thromb Res; 2010 Jul; 126(1):24-31. PubMed ID: 20185164
[TBL] [Abstract][Full Text] [Related]
10. Revisiting Filtration Fraction as an Index of the Risk of Hemofilter Clotting in Continuous Venovenous Hemofiltration.
Hatamizadeh P; Tolwani A; Palevsky P
Clin J Am Soc Nephrol; 2020 Nov; 15(11):1660-1662. PubMed ID: 32404338
[No Abstract] [Full Text] [Related]
11. A multi-center, prospective, open-label, 8-week study of certoparin for anticoagulation during maintenance hemodialysis--the membrane study.
Dorsch O; Krieter DH; Lemke HD; Fischer S; Melzer N; Sieder C; Bramlage P; Harenberg J
BMC Nephrol; 2012 Jun; 13():50. PubMed ID: 22742742
[TBL] [Abstract][Full Text] [Related]
12. Enoxaparin versus unfractioned heparin as anticoagulant for continuous venovenous hemodialysis: a randomized open-label trial.
Garcés EO; Victorino JA; Thomé FS; Röhsig LM; Dornelles E; Louzada M; Stifft J; de Holanda F; Veronese FV
Ren Fail; 2010 Jan; 32(3):320-7. PubMed ID: 20370447
[TBL] [Abstract][Full Text] [Related]
13. Anticoagulation with prostacyclin and heparin during continuous venovenous hemofiltration.
Langenecker SA; Felfernig M; Werba A; Mueller CM; Chiari A; Zimpfer M
Crit Care Med; 1994 Nov; 22(11):1774-81. PubMed ID: 7956281
[TBL] [Abstract][Full Text] [Related]
14. Continuous renal replacement therapy. Keeping the circuit open: lessons from the lab.
Shulman RI; Singer M; Rock J
Blood Purif; 2002; 20(3):275-81. PubMed ID: 11867875
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulation for continuous arteriovenous hemofiltration in children.
Zobel G; Trop M; Muntean W; Ring E; Gleispach H
Blood Purif; 1988; 6(2):90-5. PubMed ID: 3293620
[TBL] [Abstract][Full Text] [Related]
16. Shortened hemofilter survival time due to lipid infusion in continuous renal replacement therapy.
Kazory A; Clapp WL; Ejaz AA; Ross EA
Nephron Clin Pract; 2008; 108(1):c5-9. PubMed ID: 18059111
[TBL] [Abstract][Full Text] [Related]
17. Hemodialysis without anticoagulation. One-year prospective trial in hospitalized patients at risk for bleeding.
Schwab SJ; Onorato JJ; Sharar LR; Dennis PA
Am J Med; 1987 Sep; 83(3):405-10. PubMed ID: 3310620
[TBL] [Abstract][Full Text] [Related]
18. [The effects of dialysate and ultrafiltration flow rate on solute clearance during continuous renal replacement therapy].
Gong D; Ji D; Xie H; Xu B; Liu Y; Li L
Zhonghua Nei Ke Za Zhi; 2001 Mar; 40(3):183-6. PubMed ID: 11798577
[TBL] [Abstract][Full Text] [Related]
19. A Randomized Controlled Trial of Regional Citrate Versus Regional Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Adults.
Gattas DJ; Rajbhandari D; Bradford C; Buhr H; Lo S; Bellomo R
Crit Care Med; 2015 Aug; 43(8):1622-9. PubMed ID: 25853591
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulation with prostaglandins and unfractionated heparin during continuous venovenous haemofiltration: a randomized controlled trial.
Kozek-Langenecker SA; Spiss CK; Gamsjäger T; Domenig C; Zimpfer M
Wien Klin Wochenschr; 2002 Feb; 114(3):96-101. PubMed ID: 12060975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
